Navigation Links
SpineSmith to Present at the 5th Annual Stem Cell Summit
Date:2/15/2010

AUSTIN, Texas, Feb. 15 /PRNewswire/ -- Dr. Robert Johnson, MD, of Neurosurgical Associates of San Antonio, is presenting at the 5th Annual Stem Cell Summit in New York on February 16, 2010. Dr. Johnson will be presenting his most recent data proving the efficacy of point of care adult stem cell therapies in spine surgery.  Point of care technology utilizes the patient's own cells derived from bone marrow to inhibit bone growth in spinal fusion procedures.  Dr. Johnson believes promoting cell therapy utilizing the patient's own cells will change the future landscape of medicine.  

"The use of autologous stem cells is revolutionizing medical care in both the prevention and treatment of spinal disorders," said Johnson.

The annual Stem Cell Summit brings together the leading medical, financial and scientific innovators within the rapidly expanding field of regenerative medicine. SpineSmith has been an avid attendee and sponsor of the Stem Cell Summit for numerous years and built a business around the future of regenerative medicine.  SpineSmith launched Celling Technologies to research and develop cell therapies through the collaboration of scientists, engineers and medical providers in a wide spectrum of applications including spine, orthopedics, trauma, plastics, cardiovascular and disease.

Dr. James Poser, Vice President of Regenerative Medicine for Celling Technologies, believes the future of regenerative medicine is upon us and the science has quickly pushed technology to deliver results-based medicine.  Dr. Poser believes point of care technologies are quickly becoming a source for consistent, reliable and predictable results for cell therapies.

"It is through collaborative efforts like those with Dr. Johnson that Celling Technologies intends to rigorously investigate and expand the opportunities for the effective use of a patient's own cells in regenerative medicine.  The Stem Cell Summit has become a preeminent forum for sharing and discussing these developments, and we look forward to participating in this and future Summit meetings," said Poser.

About SpineSmith Partners, LP

SpineSmith Partners, LP is dedicated to creating better ways to facilitate and accelerate the healing of spinal disorders through integration of innovative medical devices and biologic technologies. SpineSmith designs, develops, and markets implants and biologics for surgical fixation, correction, and tissue regeneration of the spine.

About Celling Technologies

Celling Technologies, a SpineSmith Partners company, works closely with surgeons, scientists and engineers to research and develop innovative technologies in the emerging field of regenerative medicine.  Celling's product offering focuses on autologous adult stem cell therapies and the devices and services that complement these procedures.  

About Neurosurgical Associates of San Antonio

Neurosurgical Associates of San Antonio provides comprehensive spine care across a full spectrum of neurologic and spinal surgery.   Neurosurgical Associates of San Antonio is committed to providing state-of-the-art neurosurgical and spine care as well as the highest quality of care, compassion and excellence to patients.

www.spinesmithusa.com

www.cellingtechnologies.com

SOURCE SpineSmith Partners, LP

RELATED LINKS
http://www.spinesmithusa.com
http://www.cellingtechnologies.com

'/>"/>

SOURCE SpineSmith Partners, LP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement
2. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
3. SIU To Present System Technology & Innovation Expo March 30
4. YM BioSciences presents CYT387 and CYT997 data at international cancer conference
5. European research initiative EUREKA presented at Research & Technology for the first time
6. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
7. NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
8. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
9. Interleukin Genetics to Present at the 12th Annual BIO CEO Conference
10. The Advisory Board Company to Present at Upcoming Conferences
11. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):